Vimian Group AB (publ) (OTCMKTS:VIMGF) Sees Large Growth in Short Interest

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 546,100 shares, an increase of 18.5% from the March 15th total of 460,800 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 5,461.0 days.

Vimian Group AB (publ) Price Performance

Shares of VIMGF stock opened at C$4.50 on Monday. Vimian Group AB has a fifty-two week low of C$2.68 and a fifty-two week high of C$4.50. The stock’s 50-day moving average is C$3.84 and its two-hundred day moving average is C$3.72.

About Vimian Group AB (publ)

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.